ApoA-I knockout mice: characterization of HDL metabolism in homozygotes and identification of a post-RNA mechanism of apoA-I up-regulation in heterozygotes

This publication has 21 references indexed in Scilit:

• Human apolipoprotein A-I gene expression increases high density lipoprotein and suppresses atherosclerosis in the apolipoprotein E-deficient mouse.
  Proceedings of the National Academy of Sciences, 1994
• Apolipoprotein AI transgene corrects apolipoprotein E deficiency-induced atherosclerosis in mice.
  Journal of Clinical Investigation, 1994
• Lack of apoA-I is not associated with increased susceptibility to atherosclerosis in mice.
  Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1993
• Marked reduction of high density lipoprotein cholesterol in mice genetically modified to lack apolipoprotein A-I.
  Proceedings of the National Academy of Sciences, 1992
• Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AI
  Nature, 1991
• Expression of the human apolipoprotein A-I gene in transgenic mice alters high density lipoprotein (HDL) particle size distribution and diminishes selective uptake of HDL cholesteryl esters.
  Proceedings of the National Academy of Sciences, 1991
• Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene
  Cell, 1991
• Expression of human apolipoprotein A-I in transgenic mice results in reduced plasma levels of murine apolipoprotein A-I and the appearance of two new high density lipoprotein size subclasses.
  Proceedings of the National Academy of Sciences, 1991
• High density lipoprotein metabolism.
  Journal of Lipid Research, 1984
• The Theory of Tracer Experiments with ¹³¹I-Labelled Plasma Proteins
  Physics in Medicine & Biology, 1957